Therapy for Late Post Infarction Ventricular Tachycardia
Autor: | Brenda Butler, John C. Somberg, David Tepper, Louis Siegel, John H. Jentzer, Gad Keren, Dennis S. Miura, Vilma Torres |
---|---|
Rok vydání: | 1985 |
Předmět: |
Male
medicine.medical_specialty Heart Ventricles medicine.medical_treatment Benzeneacetamides Myocardial Infarction Infarction 030204 cardiovascular system & hematology Antiarrhythmic agent Ventricular tachycardia Sudden death Electrocardiography 03 medical and health sciences 0302 clinical medicine Piperidines Heart Rate Tachycardia Internal medicine Heart rate medicine Humans 030212 general & internal medicine Aged Clinical Trials as Topic Ejection fraction medicine.diagnostic_test business.industry Cardiac Pacing Artificial Middle Aged medicine.disease Anesthesia Cardiology Myocardial infarction complications Female Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents |
Zdroj: | Angiology. 36:181-190 |
ISSN: | 1940-1574 0003-3197 |
DOI: | 10.1177/000331978503600307 |
Popis: | Non-sustained ventricular tachycardia (VT) in the late post myocardial in farction (MI) period (7-21 days) has been reported to be a predictor of sudden death. We suspected that patients with 3 beat VT on Holter monitoring in the late infarction period would demonstrate electrical instability at electrophysio logic studies. Forty-seven patients were identified as having at least 3 beat VT on Holter monitoring. Eighteen patients refused electrophysiologic studies or were not referred by their attending physician. The mean ejection fraction of this group was 43 ± 16%. Eight patients have died, 3 sudden deaths in 13 ± 5 months, a 17% incidence of sudden death. Twenty-nine patients underwent in vasive electrophysiologic studies. Their mean ejection fraction was 37 ±7%, and 28 had inducible, 18 sustained ventricular tachycardia and 10 non-sus tained VT. No complications were noted with electrophysiological testing in the post infarction patients. Using programmed electrical stimulation studies an effective antiarrhythmic agent preventing VT induction (usually experimental) could be found for each patient. After a mean follow-up of 12.5 ± 4 months, the patient without inducible VT is alive and 26 of the 28 "inducible" patients are alive and well. Two patients died, one of stroke and one due to pump failure following a second MI. No sudden deaths were observed in this group. Two patients had breakthrough arrhythmias and were treated by alternative antiar rhythmic therapy that was also effective at the initial electrophysiologic studies. Thus, PES studies post MI are safe and may be an effective way to assess therapy for patients in the early post MI period, indentified at high risk for sudden death. |
Databáze: | OpenAIRE |
Externí odkaz: |